This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

The Psychopharmacologic Specificity of the Lithium Ion: Origins and Trajectory

Jair C. Soares, MD, and Samuel Gershon, MD

Published: July 31, 2000

Article Abstract

This article examines the development of lithium therapy since its dramatic introduction into psychiatryin 1949. Since that time, lithium has been examined in the treatment of a variety of neuropsychiatricconditions, but it is in the treatment of bipolar disorder that it is most effective. This suggeststhat it has specificity in the treatment of this disorder. These findings are very relevant as they suggestthat understanding the mechanism of action of lithium in bipolar disorder may hold keys to elucidatingits pathophysiology and to developing newer and more effective treatments. We review the publisheddata on the effectiveness of lithium in bipolar disorder and various neuropsychiatric conditionsand also the available data on anticonvulsants and newer therapeutic agents in the treatment of thiscondition.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 61

Quick Links: Bipolar Disorder

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...

Read More...